PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 32 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

21 September 2025

  1. (diff | hist) m 18:45 Certificate of analysis 9,814 ±0 VerifyFirstVida (talk | contribs) label the community tally as self-reported at this point of use as well [rollback]
  2. (diff | hist) m 18:09 Cost per milligram 4,027 ±0 ThymosinTamsin (talk | contribs) attribute the survey figure to the survey and give its sample size [rollback]
  3. (diff | hist) 14:14 Lot traceability 5,317 +230 PrimarySrcPatia (talk | contribs) state that the report identifies the sample, not the shipment [rollback]
  4. (diff | hist) 09:55 Talk:Lyophilisation 1,096 +214 AnalyticalAnnie (talk | contribs) /* Collapse temperature and Tg-prime are being used interchangeably */ reply
  5. (diff | hist) 06:15 GenScript Peptides 6,349 +2,136 ShortageShona (talk | contribs) add the incorporation year, attributed to the registry record [rollback]
  6. (diff | hist) 05:30 Nantong Guangyuan Chemical 14,421 +226 GlossaryGleb (talk | contribs) state the city and province of the registered address [rollback]

20 September 2025

  1. (diff | hist) 23:50 Good manufacturing practice 5,123 ±0 LabelLibby (talk | contribs) name the regulator rather than writing "the authorities" [rollback]
  2. (diff | hist) 19:02 Syringe dead space 5,919 +1,804 Peptide_Pete (talk | contribs) give the worked example to two significant figures throughout [rollback]
  3. (diff | hist) 18:15 PolyPeptide Group (Hangzhou) 6,060 +2,396 COA_Colwyn (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]
  4. (diff | hist) 17:58 Mass spectrometry 5,612 ±0 TFA_Counterion (talk | contribs) ce [rollback]
  5. (diff | hist) m b 07:01 Area percent purity 8,537 +1,157 CategoryBot (talk | contribs) bot: sort category members [rollback]
  6. (diff | hist) m 01:47 Prior authorisation 4,216 +135 TSH_Tallulah (talk | contribs) add the note that price is not a proxy for quality [rollback]

19 September 2025

  1. (diff | hist) 22:29 Chain of custody 5,157 +135 MTC_Marisol (talk | contribs) add the point that reports reaching this wiki are not a sample of anything [rollback]
  2. (diff | hist) 16:43 ISO 9001 4,278 +380 Compounding_Cate (talk | contribs) fix a dangling clause [rollback]
  3. (diff | hist) 15:31 Talk:Lyophilisation 885 +307 LyophilLena (talk | contribs) /* Collapse temperature and Tg-prime are being used interchangeably */ reply
  4. (diff | hist) 11:07 Talk:Lyophilisation 674 +430 StabilityStig (talk | contribs) /* Collapse temperature and Tg-prime are being used interchangeably */ new section
  5. (diff | hist) 10:41 Talk:WuXi TIDES 1,170 +181 BlindSampleBrid (talk | contribs) /* Where should the ordering facts sit? */ reply
  6. (diff | hist) m 10:35 Body composition assessment 5,029 +128 DMF_Dermot (talk | contribs) add category for laboratory medicine [rollback]
  7. (diff | hist) m 10:18 Electrospray ionisation 4,323 ±0 MassSpecMarv (talk | contribs) add the equilibration time to the gradient description [rollback]
  8. (diff | hist) m 06:55 SinoPep 9,488 +251 COA_Colwyn (talk | contribs) attribute the capability claim to the organisation's own material [rollback]
  9. (diff | hist) 02:34 Crude peptide 4,775 +229 CrudePeptidePearl (talk | contribs) expand §From crude to purified [rollback]
  10. (diff | hist) m b 00:54 Beyond-use date 20,489 +1,459 StubSorterBot (talk | contribs) bot: normalise unit spacing [rollback]
  11. (diff | hist) 00:34 Temperature excursion 17,311 +1,332 RepackRadek (talk | contribs) add the shelf temperature and the primary drying step to the cycle description [rollback]

18 September 2025

  1. (diff | hist) m 20:25 Underfilling 4,674 ±0 SatietySunniva (talk | contribs) add category for certificates of analysis [rollback]
  2. (diff | hist) m 17:32 Gastric emptying 5,565 ±0 LurkerLevi (talk | contribs) state that the enzyme inhibitor class works by raising endogenous levels [rollback]
  3. (diff | hist) m 16:47 Adverse effects of GLP-1 receptor agonists 5,791 ±0 ThymosinTamsin (talk | contribs) unpipe a link that did not need piping [rollback]
  4. (diff | hist) m 15:00 Incretin effect 7,358 +224 ThymosinTamsin (talk | contribs) state that the enzyme inhibitor class works by raising endogenous levels [rollback]
  5. (diff | hist) 13:17 Janoshik Analytical 5,235 ±0 GroupBuyGalen (talk | contribs) correct the description of how lot identifiers are assigned [rollback]
  6. (diff | hist) 12:00 Purity claim inflation 5,660 +218 UnderfillUna (talk | contribs) rm the ranking language; this wiki publishes no ranking [rollback]
  7. (diff | hist) 09:22 Talk:WuXi TIDES 959 +254 COA_Colwyn (talk | contribs) /* Where should the ordering facts sit? */ reply

17 September 2025

  1. (diff | hist) 22:19 Repackaging 4,759 ±0 RepackRadek (talk | contribs) rm the shipping recommendation — that is advice, not description [rollback]
  2. (diff | hist) 16:35 Talk:WuXi TIDES 748 +294 Chromatokid (talk | contribs) /* Where should the ordering facts sit? */ reply
  3. (diff | hist) m 16:05 Amylin 5,795 +696 TirzTaxonomist (talk | contribs) move the trade-name history out of the lead and into §Regulatory history [rollback]
  4. (diff | hist) 14:08 Talk:WuXi TIDES 537 +463 BlindSampleBrid (talk | contribs) /* Where should the ordering facts sit? */ new section
  5. (diff | hist) m b 11:48 Sangon Biotech 12,400 +261 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  6. (diff | hist) 08:54 PolyPeptide Group (Hangzhou) 3,664 +976 eGFR_Esme (talk | contribs) state what the certificate supplied with orders carries [rollback]
  7. (diff | hist) 05:14 GenScript Peptides 4,213 +229 ChainCustodyChad (talk | contribs) attribute the documentation description to the purchaser reports it comes from [rollback]
  8. (diff | hist) 05:04 Insulin syringe unit conversion 6,290 ±0 TalkPageTaro (talk | contribs) expand the table so the third syringe scale is covered [rollback]
  9. (diff | hist) 03:18 Beta cell function 6,096 ±0 IncretinIvo (talk | contribs) clarify that the receptor is expressed outside the pancreas [rollback]
  10. (diff | hist) 02:58 Triple agonist 4,269 ±0 AxisLabelAgda (talk | contribs) label the animal data as animal data in the sentence, not only in the section heading [rollback]
  11. (diff | hist) 01:43 Qingdao Saber Technology Pharmaceutical 7,549 ±0 BlankVialBo (talk | contribs) add the incorporation year, attributed to the registry record [rollback]
  12. (diff | hist) 00:30 Global access disparity 4,275 ±0 DisparityDagny (talk | contribs) clarify that coverage varies by plan and give the source for the example [rollback]

16 September 2025

  1. (diff | hist) m 23:53 Limit of detection 4,865 +315 TSH_Tallulah (talk | contribs) state the column chemistry and the gradient the figure was obtained on [rollback]
  2. (diff | hist) 20:55 C-peptide 4,400 ±0 Compounding_Cate (talk | contribs) consistent en dashes in ranges [rollback]
  3. (diff | hist) m 17:40 Shenzhen Hybio Pharmaceutical 4,766 +33 SyringeSybille (talk | contribs) rm the comparison with another supplier; there is no common basis for it [rollback]
  4. (diff | hist) 08:30 Xi'an Mokemei Biotechnology 10,560 +321 VerifyVesna (talk | contribs) add the catalogue size and label it self-reported [rollback]
  5. (diff | hist) 06:12 Hunan Aslsen Technology 13,388 +480 TrialsTabitha (talk | contribs) serial comma per PP:MOS [rollback]
  6. (diff | hist) m b 06:10 Chinese Peptide Company 15,293 +1,180 ArchiveBot (talk | contribs) bot: add supplier category [rollback]
  7. (diff | hist) 05:34 Reverse-phase HPLC 5,499 ±0 FreightFenna (talk | contribs) add the detection wavelength [rollback]
  8. (diff | hist) m b 01:47 ChinaPeptides 13,591 +1,024 CiteBot (talk | contribs) bot: update parent category chain [rollback]

15 September 2025

  1. (diff | hist) 23:30 Contract development and manufacturing organisation 5,011 +217 StopperingSteff (talk | contribs) fix the anchor on an internal link [rollback]
  2. (diff | hist) 22:59 Peptide harm reduction 4,800 ±0 ArchiveAudit (talk | contribs) correct the population figure — the source gives eligible, not treated [rollback]
  3. (diff | hist) m 12:41 Karl Fischer titration 9,318 ±0 DiluentDiya (talk | contribs) expand §Interpretation on a certificate of analysis [rollback]
  4. (diff | hist) m 10:59 Enteroendocrine L cell 5,083 ±0 Areapercent_Ayo (talk | contribs) the glucose-dependence of the insulinotropic effect deserves its own sentence [rollback]
  5. (diff | hist) m 06:33 Regulatory status by jurisdiction 4,444 ±0 Ref_Desk_Ron (talk | contribs) correct the agency abbreviation at first use [rollback]
  6. (diff | hist) m 05:54 Vial filling and stoppering 4,557 ±0 NurseNoteNessa (talk | contribs) split §Cold chain from §Storage after receipt [rollback]
  7. (diff | hist) 05:31 Syringe dead space 4,115 +1,517 Chromatokid (talk | contribs) rm the brand-specific instruction; it is not general [rollback]
  8. (diff | hist) 02:47 Hypoglycaemia 4,473 +56 AmylinAmos (talk | contribs) rm a duplicated category [rollback]
  9. (diff | hist) 01:33 Cold chain 25,931 +1,902 CustomsClarke (talk | contribs) attribute the stability figure to the study and its duration [rollback]
  10. (diff | hist) m b 01:12 Tianjin Finder Chemical 13,523 +1,067 CiteBot (talk | contribs) bot: update parent category chain [rollback]

14 September 2025

  1. (diff | hist) 23:04 Lyophilisation 27,583 +1,208 IcodecIndra (talk | contribs) add the cross-link to the temperature-excursion article [rollback]
  2. (diff | hist) 21:29 Satiety signalling 5,593 ±0 DeadSpaceDot (talk | contribs) name the enzyme responsible for the cleavage at the first mention [rollback]
  3. (diff | hist) 18:46 Zhuhai Kerui Biotechnology 8,279 +854 PrimarySrcPatia (talk | contribs) attribute the documentation description to the purchaser reports it comes from [rollback]
  4. (diff | hist) 11:04 International nonproprietary name 4,356 ±0 OralSemaOswin (talk | contribs) expand §Stems relevant here [rollback]
  5. (diff | hist) 10:52 Oral semaglutide 4,349 ±0 DulaglutideDug (talk | contribs) rm duplicated pharmacokinetics — the same figures appear in the infobox [rollback]
  6. (diff | hist) m 10:44 Proglucagon 6,709 ±0 EmptyingElke (talk | contribs) the numbers in the lead disagreed with the body; body was right [rollback]
  7. (diff | hist) m 08:46 Trial data comparison 6,523 +485 MTC_Marisol (talk | contribs) expand §Outcome trials are a different kind of evidence [rollback]
  8. (diff | hist) m 03:41 Retatrutide 7,261 ±0 OralSemaOswin (talk | contribs) convert a hard-coded date to the house format [rollback]
  9. (diff | hist) m 01:48 SUSTAIN trial programme 5,153 ±0 CounterfeitCato (talk | contribs) give the primary endpoint as pre-specified, not as reported [rollback]
  10. (diff | hist) 00:45 Aspiration risk under anaesthesia 4,681 ±0 GsCouplingGil (talk | contribs) add the citation for the gallbladder finding [rollback]
  11. (diff | hist) 00:27 Weight regain after discontinuation 4,670 ±0 RetinopathyRex (talk | contribs) state that no head-to-head comparison of tolerability exists for these two [rollback]

13 September 2025

  1. (diff | hist) 23:31 Peptide aggregation 5,516 ±0 ShortageShona (talk | contribs) rm the assertion that two laboratories must agree; they need not [rollback]
  2. (diff | hist) 22:41 Analytical method validation 5,342 ±0 Chromatokid (talk | contribs) de-orphan [rollback]
  3. (diff | hist) m 16:38 GLP-1 receptor 7,570 ±0 Chromatokid (talk | contribs) expand §Structure and ligand engagement [rollback]
  4. (diff | hist) 15:31 CagriSema 5,687 +385 CagriCass (talk | contribs) fix the amino-acid substitution — position 8, not position 2 [rollback]
  5. (diff | hist) 13:12 High-performance liquid chromatography 6,815 ±0 HyphenHarriet (talk | contribs) space between number and unit per PP:MOS [rollback]
  6. (diff | hist) m b 12:14 PolyPeptide Group (Hangzhou) 2,688 ±0 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  7. (diff | hist) m 06:38 Resin cleavage 4,310 +281 ColdChainCleo (talk | contribs) expand §Cocktails and scavengers [rollback]

12 September 2025

  1. (diff | hist) m 21:08 Personal importation policy 4,121 +324 FreightFenna (talk | contribs) consistent en dashes in ranges [rollback]
  2. (diff | hist) m 20:50 Glucagon-like peptide-1 12,102 ±0 ProglucagonPia (talk | contribs) the article treated a rodent finding as human physiology; corrected [rollback]
  3. (diff | hist) 19:13 Semaglutide 9,799 ±0 LiraLotte (talk | contribs) expand §Material sold outside licensed supply [rollback]
  4. (diff | hist) m 17:14 Shanghai ERP Biotechnology 6,332 +318 EndotoxinEd (talk | contribs) expand §Product range [rollback]
  5. (diff | hist) 17:03 Flourishglobal Peptide Biotech 10,704 +1,131 NPOV_Nadia (talk | contribs) space between number and unit per PP:MOS [rollback]
  6. (diff | hist) 15:43 Peptide 6,813 ±0 MTC_Marisol (talk | contribs) expand §Peptides as medicines [rollback]
  7. (diff | hist) 12:51 SURPASS trial programme 5,078 ±0 SurrogateSunday (talk | contribs) convert the endpoint list to a table for comparability [rollback]
  8. (diff | hist) 12:39 Liraglutide 5,967 ±0 OrphanPageOrin (talk | contribs) add category for the drug class [rollback]
  9. (diff | hist) 04:36 Customs seizure 4,516 ±0 PharmDrafts (talk | contribs) clarify the difference between a marketing authorisation and a registration [rollback]
  10. (diff | hist) 03:30 Baseline laboratory panel 4,429 ±0 Peptide_Pete (talk | contribs) close an unbalanced quotation mark [rollback]
  11. (diff | hist) 02:52 Research use only 7,724 ±0 Peptide_Pete (talk | contribs) add the telehealth prescribing point as attributed [rollback]
  12. (diff | hist) 02:15 Syringe dead space 2,598 ±0 Chromatokid (talk | contribs) expand §Terminology and reporting problems [rollback]
  13. (diff | hist) 00:57 Placebo-adjusted effect 4,805 +224 SurmountSurma (talk | contribs) add the year of publication to each trial in the list [rollback]

11 September 2025

  1. (diff | hist) 19:38 Grey market 4,068 +573 ResinRhoswen (talk | contribs) correct the freezer temperature range given for long-term storage [rollback]
  2. (diff | hist) 12:54 GL Biochem (Shanghai) 15,340 ±0 CommaCarys (talk | contribs) state what the certificate supplied with orders carries [rollback]
  3. (diff | hist) m 12:39 Residual solvent 4,819 ±0 AAA_Analyst (talk | contribs) expand §Determination and its blind spots [rollback]
  4. (diff | hist) 12:29 GenScript Peptides 3,984 +38 SiteReactionSuz (talk | contribs) clarify that no manufacturing or marketing authorisation is claimed or established [rollback]
  5. (diff | hist) 05:07 Lixisenatide 4,195 ±0 MazdutideMads (talk | contribs) add the structural figure and caption it properly [rollback]

10 September 2025

  1. (diff | hist) 16:40 Shanghai Wibson Biotechnology 11,408 +1,173 PortalPolly (talk | contribs) add the see-also to the certificate-of-analysis article [rollback]
  2. (diff | hist) 14:13 Haemoglobin A1c 4,243 ±0 SharpsSukhi (talk | contribs) add the note that a single value out of range is not a finding [rollback]
  3. (diff | hist) 11:36 Drug master file 4,325 ±0 PharmDrafts (talk | contribs) add the customs-detention point with its source [rollback]
  4. (diff | hist) 08:47 Talk:Peptide stability table 1,033 +267 StabilityStig (talk | contribs) /* Sourcing of the reconstituted-stability column */ reply